Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor)

作者:Klotz Luisa; Gruetzke Berit; Eveslage Maria; Deppe Michael; Gross Catharina C; Kirstein Lucienne; Posevitz Fejfar Anita; Schneider Hohendorf Tilman; Schwab Nicholas; Meuth Sven G; Wiendl Heinz
来源:BMC Neurology, 2015, 15(1): 96.
DOI:10.1186/s12883-015-0354-9
  • 出版日期2015-6-23